KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
Proton Therapy 2012
Dollars, Decisions, and Debates
With only 10 live centers in the U.S., speculation about the required investment and effectiveness of proton therapy is plentiful, but actual facts are in short supply. In the cancer treatment world, proton therapy is a hot topic; it is critical for some patients, as well as expensive and controversial.
This leads providers to ask many unanswered questions, including, Do we need this to compete, and if so, is the cost worth it? What is required to get an ROI? Providers also wonder about the effectiveness and potential side effects. Is proton therapy actually better than other less costly and more available radiation therapy? Which vendors play in the space and who is having success? KLAS spoke with nearly 100 providers to determine current perceptions in the market.
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.